• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可切除性软组织和皮肤血管肉瘤的预后模型。

A prognostic model for resectable soft tissue and cutaneous angiosarcoma.

作者信息

Sinnamon Andrew J, Neuwirth Madalyn G, McMillan Matthew T, Ecker Brett L, Bartlett Edmund K, Zhang Paul J, Kelz Rachel R, Fraker Douglas L, Roses Robert E, Karakousis Giorgos C

机构信息

Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.

Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

J Surg Oncol. 2016 Oct;114(5):557-563. doi: 10.1002/jso.24352. Epub 2016 Jul 4.

DOI:10.1002/jso.24352
PMID:27378102
Abstract

BACKGROUND

Angiosarcoma is an aggressive tumor rising in incidence from use of therapeutic radiation. Because of its relative rarity, prognostic factors have not been clearly delineated.

METHODS

Patients who underwent resection of localized angiosarcoma from 2002 to 2012 were identified using the National Cancer Data Base. Factors associated with poor overall survival (OS) were identified using Cox proportional hazards modeling and internally validated with bootstrap resampling. These were used to construct a risk model to identify low-, intermediate-, or high-risk groups.

RESULTS

Median OS among 821 patients undergoing resection was 3.4 years. On multivariable analysis of factors known preoperatively, those associated with worse OS included: age >70 years (HR 2.02, P < 0.0001), black race (HR 1.92, P < 0.0001), head and neck primary (HR 1.44, P = 0.003), grade 3 tumor (HR 1.53, P = 0.013), size 3-7 cm (HR 1.64, P < 0.0001), size >7 cm (HR 2.37, P < 0.0001). After including postoperative variables, positive resection margins were associated with worse OS (microscopic, HR 1.59, P = 0.002; macroscopic, HR 3.38, P = 0.008). Stratification by risk group was superior to AJCC stage in discriminating OS.

CONCLUSIONS

In the largest study to date of patients with angiosarcoma, risk factors for poor OS were identified to create a clinically useful risk model that can prognosticate patients with localized disease following surgical resection. J. Surg. Oncol. 2016;114:557-563. © 2016 Wiley Periodicals, Inc.

摘要

背景

血管肉瘤是一种侵袭性肿瘤,因放射治疗的使用而发病率上升。由于其相对罕见,预后因素尚未明确界定。

方法

使用国家癌症数据库确定2002年至2012年接受局限性血管肉瘤切除术的患者。使用Cox比例风险模型确定与总体生存(OS)不良相关的因素,并通过自助重采样进行内部验证。这些因素用于构建风险模型,以识别低、中或高风险组。

结果

821例接受切除术的患者的中位OS为3.4年。对术前已知因素进行多变量分析,与较差OS相关的因素包括:年龄>70岁(HR 2.02,P<0.0001)、黑人种族(HR 1.92,P<0.0001)、头颈部原发肿瘤(HR 1.44,P = 0.003)、3级肿瘤(HR 1.53,P = 0.013)、大小为3 - 7 cm(HR 1.64,P<0.0001)、大小>7 cm(HR 2.37,P<0.0001)。纳入术后变量后,切缘阳性与较差的OS相关(显微镜下,HR 1.59,P = 0.002;肉眼可见,HR 3.38,P = 0.008)。在区分OS方面,按风险组分层优于美国癌症联合委员会(AJCC)分期。

结论

在迄今为止关于血管肉瘤患者的最大规模研究中,确定了OS不良的风险因素,以创建一个临床有用的风险模型,该模型可对手术切除后局限性疾病患者的预后进行预测。《外科肿瘤学杂志》2016年;114:557 - 563。©2016威利期刊公司

相似文献

1
A prognostic model for resectable soft tissue and cutaneous angiosarcoma.可切除性软组织和皮肤血管肉瘤的预后模型。
J Surg Oncol. 2016 Oct;114(5):557-563. doi: 10.1002/jso.24352. Epub 2016 Jul 4.
2
Neoadjuvant radiation for cutaneous and soft tissue angiosarcoma.新辅助放疗在皮肤和软组织血管肉瘤中的应用。
J Surg Oncol. 2022 Mar;125(3):509-515. doi: 10.1002/jso.26727. Epub 2021 Oct 24.
3
Investigation of Prognostic Features in Primary Cutaneous and Soft Tissue Angiosarcoma After Surgical Resection: A Retrospective Study.手术切除后原发性皮肤和软组织血管肉瘤预后特征的调查:一项回顾性研究。
Ann Plast Surg. 2017 Mar;78(3 Suppl 2):S41-S46. doi: 10.1097/SAP.0000000000001004.
4
Survival outcomes for cutaneous angiosarcoma of the scalp versus face.头皮与面部皮肤血管肉瘤的生存结果。
Head Neck. 2017 Jun;39(6):1205-1211. doi: 10.1002/hed.24747. Epub 2017 Apr 11.
5
Treatment and outcome of 82 patients with angiosarcoma.82例血管肉瘤患者的治疗及预后
Ann Surg Oncol. 2007 Jun;14(6):1953-67. doi: 10.1245/s10434-006-9335-y. Epub 2007 Mar 14.
6
Angiosarcoma of the scalp and face: the Mayo Clinic experience.头皮和面部血管肉瘤:梅奥诊所的经验
JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):335-40. doi: 10.1001/jamaoto.2014.3584.
7
Patterns of Care and Survival of Cutaneous Angiosarcoma of the Head and Neck.头颈部皮肤血管肉瘤的治疗模式和生存情况。
Otolaryngol Head Neck Surg. 2020 Jun;162(6):881-887. doi: 10.1177/0194599820905495. Epub 2020 Feb 11.
8
Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.原发性头颈部血管肉瘤的特征与预后:一项基于监测、流行病学和最终结果计划(SEER)的1250例病例分析
Head Neck Pathol. 2019 Sep;13(3):378-385. doi: 10.1007/s12105-018-0978-3. Epub 2018 Oct 24.
9
Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy.乳房放射性相关血管肉瘤:罕见的继发性恶性肿瘤,预后不良。
Ann Surg Oncol. 2012 Nov;19(12):3801-8. doi: 10.1245/s10434-012-2563-4. Epub 2012 Aug 14.
10
The importance of surgery in scalp angiosarcomas.手术在头皮血管肉瘤中的重要性。
Surg Oncol. 2018 Dec;27(4):A3-A8. doi: 10.1016/j.suronc.2018.07.010. Epub 2018 Sep 13.

引用本文的文献

1
Trends in the incidence, survival, and prognostic nomogram of angiosarcoma in the United States.美国血管肉瘤的发病率、生存率及预后列线图趋势
Medicine (Baltimore). 2025 Jan 3;104(1):e41152. doi: 10.1097/MD.0000000000041152.
2
A Population-Based Long-Term Follow-Up of Soft Tissue Angiosarcomas: Characteristics, Treatment Outcomes, and Prognostic Factors.基于人群的软组织血管肉瘤长期随访:特征、治疗结果及预后因素
Cancers (Basel). 2024 May 11;16(10):1834. doi: 10.3390/cancers16101834.
3
Current understanding of angiosarcoma: disease biology and evolving treatment.
血管肉瘤的当前认识:疾病生物学与不断发展的治疗方法
Arch Craniofac Surg. 2023 Oct;24(5):203-210. doi: 10.7181/acfs.2023.00409. Epub 2023 Oct 20.
4
Utility of Multimodal Treatment Protocols in the Management of Scalp Cutaneous Angiosarcoma.多模式治疗方案在头皮皮肤血管肉瘤管理中的效用
Plast Reconstr Surg Glob Open. 2023 Mar 3;11(3):e4827. doi: 10.1097/GOX.0000000000004827. eCollection 2023 Mar.
5
Cutaneous Angiosarcoma of the Head and Neck-A Retrospective Analysis of 47 Patients.头颈部皮肤血管肉瘤——47例患者的回顾性分析
Cancers (Basel). 2022 Aug 8;14(15):3841. doi: 10.3390/cancers14153841.
6
Outcomes of Interventions for Angiosarcoma.血管肉瘤的干预结果
Front Surg. 2022 Apr 11;9:819099. doi: 10.3389/fsurg.2022.819099. eCollection 2022.
7
A Multidisciplinary Approach to Complex Dermal Sarcomas Ensures an Optimal Clinical Outcome.对复杂皮肤肉瘤采用多学科方法可确保获得最佳临床结果。
Cancers (Basel). 2022 Mar 26;14(7):1693. doi: 10.3390/cancers14071693.
8
Prognostic nomograms for predicting overall survival and cancer-specific survival in patients with angiosarcoma, a SEER population-based study.基于 SEER 人群的研究:用于预测血管肉瘤患者总生存和癌症特异性生存的预后列线图。
Sci Rep. 2022 Mar 3;12(1):3479. doi: 10.1038/s41598-022-07444-5.
9
Management of Cutaneous Angiosarcoma: an Update Review.皮肤血管肉瘤的管理:最新综述
Curr Treat Options Oncol. 2022 Feb;23(2):137-154. doi: 10.1007/s11864-021-00933-1. Epub 2022 Feb 19.
10
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology.局限性血管肉瘤,并非单一疾病:一项基于原发部位和病因的预后回顾性单中心研究
Sarcoma. 2021 Sep 10;2021:9960085. doi: 10.1155/2021/9960085. eCollection 2021.